Trade Experts: Financing Not IP Slows Adoption Of Clean Energy Tech 04/07/2016 by Priti Patnaik for Intellectual Property Watch Leave a Comment Constraints on financing, restrictions on services and not so much access to technology emerged as one of the biggest challenges in the innovation, deployment and diffusion of clean energy technologies during an unusual session last week in Geneva which brought together climate scientists and trade policy wonks. Technologists and chemical engineers also came together to discuss how unlocking trade could help clean technologies in the context of the implementation of the Paris agreement on climate change.
Access To Medicines Resolution Adopted By UN Human Rights Council 01/07/2016 by Catherine Saez, Intellectual Property Watch 4 Comments A resolution on access to medicines proposed by a number of developing countries was adopted today by the United Nations Human Rights Council, as well as a resolution on enhancing capacity-building in public health. This marks yet another United Nations fora in which developing countries seek to raise the issue of access to medicines, particularly with regard to high prices.
WIPO Patent Law Committee Adopts Work Programme; Good Omen, Some Say 30/06/2016 by Catherine Saez, Intellectual Property Watch 1 Comment World Intellectual Property Organization members attending this week’s patent law committee meeting agreed on a work programme, reflecting divergent views on patents and health, exceptions and limitations, and patent quality.
Africa Regional Group Proposes Patents And Health Programme At WIPO 29/06/2016 by Catherine Saez, Intellectual Property Watch Leave a Comment This week in the World Intellectual Property Organization patent law committee, the African Group submitted an updated proposal for a work programme on patents and health that would help developing countries tailor patent law to their circumstances.
A Comprehensive And Fair Solution To The Price Of Medicines 29/06/2016 by Intellectual Property Watch, Intellectual Property Watch 1 Comment WHO’s Marie-Paule Kieny writes: Amid public outcry, political battles and media articles, no one seems to understand how, exactly, medicines prices are set. For years, pharmaceutical research companies have cited the large investment of time and resources that go into bringing a drug to market. More recently, they argue that their medicines are actually saving money by preventing expensive medical interventions like surgery and hospitalization. But whatever the argument used, the price setting mechanisms for commodities that are inextricably linked to people’s health and survival must be made more transparent so that we can, as a global community, devise effective solutions.
Clinton Lays Out Presidential Tech & Innovation Plans 29/06/2016 by William New, Intellectual Property Watch 2 Comments US presidential candidate Hillary Clinton has issued highlights of her plan to boost the nation’s competitiveness in and attention to technology, internet and innovation if elected. The platform hits many of the latest issues and buzzwords in those fields, continuing existing programs but also pushing further in some areas. Among the plans: appoint a chief innovation advisor, reduce frivolous patent litigation, support allowing the US Patent and Trademark Office to keep its fees, boost access to orphan copyrighted works and open licensing, support multi-stakeholder internet governance, and keep the internet open worldwide. Clinton also gave a nod to personal privacy online and took a jab at the SOPA bill that was defeated for over-reaching on behalf of IP rightsholders.
WIPO Patent Law Committee Undertakes Many Issues This Week 27/06/2016 by William New, Intellectual Property Watch Leave a Comment The World Intellectual Property Organization Committee on the Law of Patents (SCP) is meeting this week. Among the possible agenda items: updates to the international patent system, exceptions and limitations to patents, quality of patents, patents and health, confidentiality of client-patent advisor communications, and technology transfer. A recent developed country proposal relates to increased work-sharing among patent offices. Also on the table this week is a new proposal to study the assessment of inventive step by patent practitioners.
UK “Brexit” Leaves IP Community With Many Questions 24/06/2016 by Dugie Standeford for Intellectual Property Watch and William New 7 Comments Britons’ 23 June decision to pull out of the European Union has caused shock waves in the UK and Europe, and the vote is still being digested. Early reactions from members of the intellectual property community show that the impact of Brexit on IP policies and issues in Britain and Europe is far from clear.
LinkedIn’s Patent Portfolio; Looking For Hidden Gems 23/06/2016 by Intellectual Property Watch 2 Comments John Sullivan writes: It’s obvious that this acquisition isn’t necessarily about the IP assets of LinkedIn. However, let’s have a closer look at LinkedIn’s portfolio to see if there are any hidden gems inside that would represent a nice fringe benefit to what already looks like a mutually beneficial acquisition.
US High Court Inter Partes Review Leaves Patent Holders Dissatisfied 21/06/2016 by Dugie Standeford for Intellectual Property Watch 1 Comment A 20 June decision by the Supreme Court upholding US Patent and Trademark Office (USPTO) rules for inter partes review of patents isn’t helpful to patent owners, according to several attorneys. The ruling in Cuozzo Speed Technologies, LLC v. Lee (No. 15-446) disappointed expectations for another pro-patent holder decision following a 13 June ruling in another case, said Proskauer patent lawyer Baldassare Vinti. USPTO Director Michelle Lee, however, said the decision would allow the office to continue resolving patentability disputes via less expensive alternatives to litigation.